# DESCRIPTION

## FIELD OF INVENTION

- relate to cancer treatment

## BACKGROUND

- discuss cancer etiology and current therapies

## SUMMARY

- introduce cancer treatment method
- describe method embodiments

## DEFINITIONS

- define cancer
- define inhibit proliferation of cancer cell
- define detecting
- define diagnosing
- define tumor
- define precancerous
- define tumor-cell killing
- define anti-P2X7 antibody
- define immunoassay
- define specifically binds to an antibody
- define various other terms

## DETAILED DESCRIPTION OF THE INVENTION

- introduce cancer treatment using P2X7 receptor agonist

### I. Cancer

- define cancer and its causes
- describe types of cancers and their symptoms

### II. Apoptosis

- define apoptosis and its role in cell death
- describe mechanisms of apoptosis
- discuss intrinsic and extrinsic pathways of apoptosis
- explain role of apoptosis in cancer development
- discuss therapeutic approaches targeting apoptosis
- relate P2X7 receptor to apoptosis and cancer development

### II. P2X Receptor Family

- describe P2X7 receptor gene structure and localization
- summarize P2X7 receptor function and ligand
- motivate P2X7 receptor role in cell growth and apoptosis
- describe P2X7 receptor-mediated apoptosis mechanisms
- discuss P2X7 receptor expression and regulation in epidermal tissues
- describe P2X7 receptor structure and topology
- summarize P2X7 receptor signaling pathways and pore formation
- discuss regulation of P2X7 receptor activity and expression
- describe P2X7 receptor family
- regulate receptor glycosylation
- regulate receptor oligomerization
- describe estrogen regulation of P2X7-mediated apoptosis
- describe biological effects of P2X7 receptor activation
- describe P2X7 receptor's role in normal epithelial cell growth
- describe P2X7 receptor's role in cancer epithelial cell growth
- describe mechanisms of attenuated P2X7-mediated apoptosis in cancer cells

### III. Cancer Treatment

- motivate P2X7 receptor as cancer treatment
- summarize limitations of systemic ATP treatment
- describe intraperitoneal ATP treatment effects
- introduce BzATP as P2X7 receptor agonist
- describe BzATP properties and effects
- summarize BzATP-induced apoptosis in skin cells
- describe method for treating and preventing cancer
- outline anti-cancer agent screening method
- contemplate method for treating human epithelial cancers
- describe P2X7 receptor expression in normal cells
- compare P2X7 receptor expression in normal and cancer cells
- analyze effects of BzATP on P2X7 expression and apoptosis
- investigate P2X7-mediated cell apoptosis
- examine in vitro effects of exogenous BzATP on apoptosis
- study in vitro recombinant P2X7 expression and its effects on apoptosis
- describe in vivo tolerability of BzATP
- describe in vivo long-term effects of BzATP
- study effects of BzATP on cancerous tissue development
- analyze papilloma development in DMBA/TPA-treated mice
- analyze papilloma size and involution in DMBA/TPA-treated mice
- study progression of papillomas to squamous spindle-cell carcinomas
- evaluate effects of BzATP on skin lesions and cancerous transformation
- describe cancer treatment
- analyze lesion sizes
- motivate BzATP-augmented apoptosis
- describe P2X7 receptor expression
- explain calcium pore formation
- analyze cytosolic calcium and influx
- discuss extracellular calcium dependence
- describe effects on cellular proliferation
- summarize mechanism of BzATP action

### IV. P2X7 Receptor Expression Regulation

- motivate P2X7 receptor expression upregulation
- elucidate active promoter region
- analyze regions distal to TpIS
- demonstrate demethylation increases P2X7 receptor expression
- investigate P2X7 receptor expression regulation
- analyze CpG site methylation in cancer cells
- identify enhancer regions and protein binding sites
- describe P2X7 expression regulator proteins
- discuss role of p53 in P2X7 receptor expression
- propose method for treating cancer by modulating P2X7 transcription
- summarize findings on P2X7 receptor expression regulation in cancer cells

### V. Administration of P2X7 Receptor Agonists

- describe administration routes
- formulate liposomes for delivery
- modify liposomes for targeted delivery

### VI. P2X7 Receptor Agonist Pharmaceutical Formulations

- formulate pharmaceutical compositions

## EXPERIMENTAL

- list materials and methods

### Human Keratinocyte Cell Cultures and Transfections

- describe cell cultures and transfections

### Protein Assays

- describe protein assays

### P2X7 mRNA in-situ Hybridization

- describe in-situ hybridization

### Real-Time PCR

- describe real-time PCR

### Example V

- describe ATP assays
- describe apoptosis assays
- describe P2X7-antisense oligonucleotides
- describe animal experiments
- describe ALT and AST assays
- describe data analysis
- describe mouse keratinocyte cell culture
- describe cytosolic calcium, ethidium-bromide, DNA synthesis, and BzATP effects assays
- describe in vivo treatment of mice with BzATP
- establish cell cultures
- elucidate promoter region of P2X7 gene
- determine transcription initiation start site
- mutate CpG sites and analyze promoter activity
- perform apoptosis assays and DNA methylation analysis
- evaluate and analyze data

